Lotus Biovet India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 02-07-2024
- Paid Up Capital ₹ 0.10 M
as on 02-07-2024
- Company Age 15 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2022)
- Profit 8.20%
(FY 2022)
- Ebitda 8.65%
(FY 2022)
- Net Worth -11.24%
(FY 2022)
- Total Assets -11.19%
(FY 2022)
About Lotus Biovet India
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Arun Marupuru, Srihari Mangalapuru, and Surekha Marupuru serve as directors at the Company.
- CIN/LLPIN
U15339KA2009PTC048932
- Company No.
048932
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jan 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Lotus Biovet India?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arun Marupuru  | Director | 01-Oct-2015 | Current |
| Srihari Mangalapuru | Director | 02-Sep-2013 | Current |
| Surekha Marupuru | Director | 20-Aug-2013 | Current |
Financial Performance of Lotus Biovet India.
Lotus Biovet India Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 8.2% increase in profit. The company's net worth observed a substantial decline by a decrease of 11.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lotus Biovet India?
In 2020, Lotus Biovet India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mvr Research And Breeding Farms LlpActive 8 years 3 monthsArun Marupuru, Srihari Mangalapuru and 1 more are mutual person
- Marupuru Estates Private LimitedActive 3 years 6 months
Arun Marupuru and Surekha Marupuru are mutual person
- Elements Of Nature Lifespaces Private LimitedActive 1 year 7 months
Arun Marupuru is a mutual person
- D.S.S. Plantations LlpActive 8 years 3 months
Srihari Mangalapuru and Surekha Marupuru are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Lotus Biovet India?
Unlock and access historical data on people associated with Lotus Biovet India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lotus Biovet India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lotus Biovet India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
